These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36638589)

  • 1. Granuloma annulare after SARS-CoV-2 vaccination: A case report and a literature review.
    Russo D; Accarino R; Varricchio S; Franca RA; Potestio L; Patruno C; Napolitano M; Mascolo M
    Pathol Res Pract; 2023 Feb; 242():154300. PubMed ID: 36638589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune mucocutaneous blistering diseases after SARS-Cov-2 vaccination: A Case report of Pemphigus Vulgaris and a literature review.
    Calabria E; Canfora F; Mascolo M; Varricchio S; Mignogna MD; Adamo D
    Pathol Res Pract; 2022 Apr; 232():153834. PubMed ID: 35278817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case of Pilomatricoma After Coronavirus Disease 2019 Vaccination.
    Nakazono M; Kawai M; Mizukami A; Kondoh A; Yamaoka H; Mabuchi T
    Tokai J Exp Clin Med; 2023 Apr; 48(1):10-12. PubMed ID: 36999388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Case of Leukocytoclastic Vasculitis Following SARS-COV-2 Vaccination.
    Ball-Burack MR; Kosowsky JM
    J Emerg Med; 2022 Aug; 63(2):e62-e65. PubMed ID: 35690533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial.
    Chen GL; Li XF; Dai XH; Li N; Cheng ML; Huang Z; Shen J; Ge YH; Shen ZW; Deng YQ; Yang SY; Zhao H; Zhang NN; Zhang YF; Wei L; Wu KQ; Zhu MF; Peng CG; Jiang Q; Cao SC; Li YH; Zhao DH; Wu XH; Ni L; Shen HH; Dong C; Ying B; Sheng GP; Qin CF; Gao HN; Li LJ
    Lancet Microbe; 2022 Mar; 3(3):e193-e202. PubMed ID: 35098177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous manifestations of COVID-19 and COVID-19 vaccination.
    Nakashima C; Kato M; Otsuka A
    J Dermatol; 2023 Mar; 50(3):280-289. PubMed ID: 36636825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial.
    Mallory RM; Formica N; Pfeiffer S; Wilkinson B; Marcheschi A; Albert G; McFall H; Robinson M; Plested JS; Zhu M; Cloney-Clark S; Zhou B; Chau G; Robertson A; Maciejewski S; Hammond HL; Baracco L; Logue J; Frieman MB; Smith G; Patel N; Glenn GM;
    Lancet Infect Dis; 2022 Nov; 22(11):1565-1576. PubMed ID: 35963274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphohistiocytic Myocarditis Possibly Due to Moderna mRNA-1273 Vaccine.
    Chow BT; Lai CK
    Am J Clin Pathol; 2022 Aug; 158(2):167-172. PubMed ID: 35285858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multisystem Inflammatory Syndrome in Adults After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Coronavirus Disease 2019 (COVID-19) Vaccination.
    Belay ED; Godfred Cato S; Rao AK; Abrams J; Wilson WW; Lim S; Newton-Cheh C; Melgar M; DeCuir J; Webb B; Marquez P; Su JR; Meng L; Grome HN; Schlaudecker E; Talaat K; Edwards K; Barnett E; Campbell AP; Broder KR; Bamrah Morris S
    Clin Infect Dis; 2022 Aug; 75(1):e741-e748. PubMed ID: 34849680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective multicenter study on cutaneous reactions reported after Sinopharm COVID-19 vaccination.
    Shawky A; Elrewiny EM; Gharib K; Sallam M; Mansour M; Rageh MA
    Int J Dermatol; 2023 Feb; 62(2):221-224. PubMed ID: 35959522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2-related and Covid-19 vaccine-induced thromboembolic events: A comparative review.
    Afshar ZM; Barary M; Babazadeh A; Hosseinzadeh R; Alijanpour A; Miri SR; Sio TT; Sullman MJM; Carson-Chahhoud K; Langer F; Ebrahimpour S
    Rev Med Virol; 2022 Jul; 32(4):e2327. PubMed ID: 35112763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature.
    Jarius S; Bieber N; Haas J; Wildemann B
    J Neurol; 2022 Oct; 269(10):5198-5212. PubMed ID: 35737110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous Small-vessel Vasculitis after ChAdOx1 COVID-19 Vaccination: A Report of Five Cases.
    Uh JA; Lee SK; Kim JH; Lee JH; Kim MS; Lee UH
    Int J Low Extrem Wounds; 2022 Jun; 21(2):193-196. PubMed ID: 35130095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccine: Postvaccination ASIA Syndrome.
    İremli BG; Şendur SN; Ünlütürk U
    J Clin Endocrinol Metab; 2021 Aug; 106(9):2600-2605. PubMed ID: 34043800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chilblain-like lesions onset during SARS-CoV-2 infection in a COVID-19-vaccinated adolescent: case report and review of literature.
    Paparella R; Tarani L; Properzi E; Costantino F; Saburri C; Lucibello R; Richetta A; Spalice A; Leonardi L
    Ital J Pediatr; 2022 Jun; 48(1):93. PubMed ID: 35698236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary Syphilis Presentation and Urticarial Eruption After Moderna COVID-19 Vaccination.
    Brockshus A; Evans MO; Punch C
    Mil Med; 2023 Mar; 188(3-4):844-847. PubMed ID: 35778833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New-onset pediatric nephrotic syndrome following Pfizer-BioNTech SARS-CoV-2 vaccination: a case report and literature review.
    Nakazawa E; Uchimura T; Hirai Y; Togashi H; Oyama Y; Inaba A; Shiga K; Ito S
    CEN Case Rep; 2022 May; 11(2):242-246. PubMed ID: 34782983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Graves' Disease After SARS-CoV-2 mRNA Vaccination: A Case Report and Literature Review.
    Lui DTW; Lee KK; Lee CH; Lee ACH; Hung IFN; Tan KCB
    Front Public Health; 2021; 9():778964. PubMed ID: 34888290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.